Silent Nite® 3D
Silent Nite® 3D logo

Silent Nite® 3D Sleep Appliance

$247*

*Price is per appliance and does not include shipping or applicable taxes.

Please note pricing is only available to dental professionals.

3D-printed and custom-fitted, the Silent Nite® 3D Sleep Appliance treats sleep-disordered breathing comfortably and effectively.

  • Precision fit due to fully digital workflow**
  • Designed with more tongue space for enhanced comfort
  • Metal-free and adjustable in 0.5 mm increments, with up to 10 mm of advancement
  • Each case includes extra connectors and a free AM Aligner®

**All impressions must be submitted digitally to ensure maximum accuracy and speed; prescriptions via traditional impressions will be filled with a thermoformed Silent Nite appliance.
AM Aligner is a registered trademark of Airway Technologies, LLC.

3-Day

IN-LAB WORKING TIME

3D-Printed

MANUFACTURING METHODS

2-Year

WARRANTY

Maximize Treatment Success with the Fully Digital Sleep Solution

The Silent Nite 3D is a digitally designed, 3D-printed sleep device that helps to alleviate the symptoms of snoring and mild to moderate obstructive sleep apnea (OSA). Manufactured with a digital workflow in mind, the appliance is an extension of the Silent Nite brand, which has been used to treat snoring and OSA since 1996.

An extra Titration Kit is included in each case, so patients can replace lost connectors or change the connector length for improved function or comfort.

Silent Nite® 3D
A dentist showing a patient the Silent Nite 3D Sleep Appliance

Built For Patient Comfort

Glidewell accepts digital-only impressions for the Silent Nite 3D appliance. This streamlines the in-office workflow and ensures a precise fit and maximum comfort for the patient. The device is adjustable in 0.5 mm increments, producing up to 10 mm of mandibular advancement. Since the process is fully digital, replacement devices — due to either damage or loss — can be fabricated without needing new impressions. If a dental practice doesn’t have an intraoral scanner, dentists may still prescribe the original Silent Nite Sleep Appliance by submitting analog impressions.

Validations

Patient Satisfaction

Oral appliance therapy (OAT) is very effective in treating patients with sleep-disordered breathing, with a compliance rate shown to be as high as 90% over a 2.5-year period.1

OAT is associated with greater patient satisfaction than nasal continuous positive airway pressure (CPAP) therapy.2

In a randomized crossover trial comparing OAT to CPAP in patients with obstructive sleep apnea, about 81% preferred OAT.3

Sleep Device Healthy Couple

Improved Health

Among patients with obstructive sleep apnea, both continuous positive airway pressure (CPAP) and mandibular advancement devices (MADs) were associated with reductions in blood pressure. Network meta-analysis did not identify a statistically significant difference between the blood pressure outcomes associated with these therapies.4

A mandibular advancement device for obstructive sleep apnea reduces nocturnal blood pressure in women.5

Healthy Couple

Specifications

Indications

The Silent Nite 3D Sleep Appliance is indicated to reduce snoring and mild to moderate obstructive sleep apnea (OSA) in patients 18 years of age or older. The appliance is worn while sleeping to support the lower jaw in a forward position as determined by the dentist. The appliance is removable by the patient.


Material Composition

Biocompatible, light-cured resin material and nylon connectors

In-Lab Working Times

3 days

Available Colors

Clear with purple tint


Pricing

Silent Nite® 3D Sleep Appliance (3 days in lab) (buy 1)
$247.00
Glidewell Clinical Twinpak(buy 2)1
$394.00
1

Glidewell Clinical Twinpak is valid for two appliances for the same case.

Pricing is subject to change and does not include shipping or applicable taxes.
 

View full price list


Policies & Warranty

NO-FAULT REMAKE POLICY: Glidewell is pleased to process all remakes or adjustments at no additional charge if requested within the warranty period and accompanied by the return of the original appliance.

LIMITED WARRANTY/LIMITATION OF LIABILITY. Glidewell (“the lab”) warrants that all dental devices (a “device”) are made according to your specification and approval in the belief that the device will be useful and MAKES NO OTHER WARRANTIES INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Subject to the return of a device that is placed and then fails, the lab will repair or replace the device without charge for the cost of materials and workmanship or refund the original price paid, at the lab’s option, for up to 2 years for the Silent Nite 3D Sleep Appliance.

Resources

Procedures

    Loading results...

    Additional Resources

    Literature

      Loading results...

      Media

      Categories
          Loading results...

          References

          1. ^ Yoshida K. Effects of a mandibular advancement device for the treatment of sleep apnea syndrome and snoring on respiratory function and sleep quality. Cranio. 2000 Apr;18(2):98-105.
          2. ^ Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs. nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest. 1996 May;109(5):1269-75.
          3. ^ Tan YK, L’Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, Spiro SG, Battagel JM. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod. 2002 Jun;24(3):239-49.
          4. ^ Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs. mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA. 2015 Dec 1;314(21):2280-93.
          5. ^ Rietz H, Franklin KA, Carlberg B, Sahlin C, Marklund M. Nocturnal blood pressure is reduced by a mandibular advancement device for sleep apnea in women: findings from secondary analyses of a randomized trial. J Am Heart Assoc. 2018 Jun 21;7(13).